Last $22.43 USD
Change Today -1.11 / -4.72%
Volume 387.7K
FMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alexis Borisy A.M.

Co-Founder, Chairman and Chairman of Compensation Committee, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 194 board members in 10 different organizations across 9 different industries.

See Board Relationships
42$25,333

Background*

Mr. Alexis Borisy, A.M., has been a Partner at Third Rock Ventures II, L.P., and Third Rock Ventures, LLC since 2010. Mr. Borisy joined Third Rock Ventures in 2009 as an Entrepreneur-in-Residence. He focuses on the formation, development, and strategy of new companies with a particular focus in personalized medicine. He served as an Interim Chief Executive Officer of Blueprint Medicines Corp., which he co-founded. He served as an Interim Chief Executive Officer at Warp ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

Director
Board Observer
Director
Former Chairman
Co-Founder and Director
Director
Director
2000-N/A
Co Founder
2009-Present
Co-Founder, Chairman and Chairman of Compensation Committee
2013-Present
Founder and Executive Chairman
2014-Present
Director

Education*

MA
Harvard University
BA
The University of Chicago
BS
The University of Chicago

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$25,333
Total Calculated Compensation$25,333
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $22.43 USD -1.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.